Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPod Point Regulatory News (PODP)

  • There is currently no data for PODP

Second Manufacturer Contract

10 Jun 2022 15:00

RNS Number : 5229O
Pod Point Group Holdings PLC
10 June 2022
 

10 June 2022

 

Pod Point Group Holdings plc

(the "Company" or "Pod Point")

 

Second Manufacturer Contract

 

Pod Point, one of the UK's market leading providers of Electric Vehicle ("EV") charging solutions, is pleased to announce that it has signed an agreement with Celestica, a leader in design, manufacturing and supply chain solutions for the world's most innovative companies, to manufacture some of its EV charge point product range. 

 

"We are delighted to partner with Celestica in manufacturing our Pod Point designed product. This partnership is a key part of Pod Point's scale up, and will allow us to continue to grow our business and accelerate towards our vision of a future where travel does not damage the earth." - Erik Fairbairn, Chief Executive Officer of Pod Point

 

" Supporting the electrification of transportation is at the core of our smart energy strategy. We are partnering with Pod Point to bring their EV charging solutions to market through our engineering, manufacturing and after-market services capabilities". - Brian Casey, VP, Industrial and Smart Energy, Celestica

 

 

 

Enquiries

Tulchan Communications(Public relations advisor to Pod Point)

+44 207 353 4200

Pod Point@tulchangroup.com

James Macey White, Mark Burgess, Matt Low, Laura Marshall, Arthur Rogers 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTEADKEFSPAEFA
Date   Source Headline
27th Sep 20224:36 pmRNSPrice Monitoring Extension
2nd Sep 20227:00 amRNSExercise of Options and Issue of New Shares
16th Aug 20227:00 amRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNSHalf-year Report
30th Jun 20227:00 amRNSCFO Designate Appointment
10th Jun 20223:00 pmRNSSecond Manufacturer Contract
8th Jun 20226:30 pmRNSBlock listing Interim Review
27th May 20224:36 pmRNSPrice Monitoring Extension
9th May 20225:45 pmRNSPublication of Annual Financial Report (updated)
9th May 20224:43 pmRNSPublication of Annual Financial Report
4th May 20222:28 pmRNSDirector Declaration
11th Apr 202212:05 pmRNSNew Contract Win
14th Mar 20224:30 pmRNSDirector/PDMR Shareholding
11th Mar 20225:25 pmRNSDirector Declaration
21st Feb 20229:00 amRNSEstablishment of new ESG Committee
18th Feb 20227:00 amRNSPreliminary Unaudited Results for FY2021
6th Jan 20227:00 amRNSTrading Update and Notice of Results
4th Jan 202211:00 amRNSTotal Voting Rights
20th Dec 20215:30 pmRNSDirector Declaration
20th Dec 20214:00 pmRNSAppointment of Joint Corporate Brokers
3rd Dec 20216:33 pmRNSExercise of Over-allotment Option
3rd Dec 20214:57 pmRNSPost-Stabilisation Period Announcement
3rd Dec 20212:15 pmRNSBlock Listing Application
1st Dec 202110:06 amRNSTotal Voting Rights
25th Nov 20214:13 pmRNSNew Contract Win
16th Nov 202111:57 amRNSHolding(s) in Company - Replacement
12th Nov 20217:00 amRNSMid-stabilisation Period Announcement
11th Nov 20214:38 pmRNSHolding(s) in Company
9th Nov 20217:21 amRNSAdmission to Trading on the London Stock Exchange
4th Nov 20211:51 pmRNSApproval and Publication of Prospectus
4th Nov 20217:00 amRNSPre-Stabilisation Period Notice
4th Nov 20217:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.